ENTRY       D11036            Mixture   Drug
NAME        Glycopyrrolate and formoterol;
            Bevespi (TN)
PRODUCT     BEVESPI AEROSPHERE (AstraZeneca Pharmaceuticals LP)
COMPONENT   Glycopyrrolate [DR:D00540], (Formoterol fumarate [DR:D01373] | Formoterol fumarate hydrate [DR:D05277] | Formoterol [DR:D07990])
REMARK      Therapeutic category: 2259
            ATC code: R03AL07
            Product: D11036<JP/US>
EFFICACY    Bronchodilator
  DISEASE   Chronic obstructive pulmonary disease [DS:H01714]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
               R03A ADRENERGICS, INHALANTS
                R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
                 R03AL07 Formoterol and glycopyrronium bromide
                  D11036  Glycopyrrolate and formoterol &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Bronchodilator Combinations
               Glycopyrrolate/ Formoterol Fumarate
                D11036  Glycopyrrolate and formoterol
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              22  Respiratory organ agents
               225  Bronchodilators
                2259  Others
                 D11036  Glycopyrrolate and formoterol
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11036
DBLINKS     PubChem: 350078355
///
